Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function.

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Biology

Background:

• Osteoactivin (OA) is a newly identified glycoprotein.
• OA expression is elevated during osteoblast differentiation.

Purpose of the Study:

• To investigate the isoforms, cellular localization, and functional role of Osteoactivin (OA) in osteoblast differentiation.
• To elucidate OA's mechanism in regulating bone formation.

Main Methods:

• Western blot analysis to identify OA isoforms.
• Cellular fractionation and EGFP-tagging to determine OA localization.
• In vitro studies using primary osteoblast cultures, retinoic acid, tunicamycin, and anti-OA antibodies.
• Gain-of-function studies with pBABE viral system and analysis of OA mutant mice.

Main Results:

• OA exists in two isoforms: transmembrane and secreted.
• OA protein is glycosylated and accumulates in vesicles for cell membrane transport.
• OA expression peaks during late osteoblast differentiation.
• Retinoic acid stimulates OA mannosylation; tunicamycin inhibits N-glycans.
• Blocking OA function with antibodies reduces osteoblast differentiation.
• OA overexpression enhances osteoblast differentiation and function.
• OA mutant mice exhibit reduced osteoblast differentiation and mineralization.

Conclusions:

• Osteoactivin (OA) is a critical positive regulator of osteoblastogenesis.
• OA is essential for terminal osteoblast differentiation and bone mineralization.
• OA's isoforms and post-translational modifications influence its function in bone formation.